Results 241 to 250 of about 282,881 (309)
Plant-based production of virus-like particles from hepatitis C virus. [PDF]
López-Castillo LM +4 more
europepmc +1 more source
Bulevirtide increases bile acid levels in most patients; however, changes in bile acids do not predict virological response or adverse events, nor do they reflect treatment adherence. After discontinuation of bulevirtide, bile acid levels rapidly decline.
Marlene Hintersteininger +14 more
wiley +1 more source
A Case Report of Rare MOG Antibody-Associated Optic Neuritis Related to Hepatitis E Virus Infection. [PDF]
Yang X +11 more
europepmc +1 more source
In 59,946 chronic hepatitis B patients followed over 23 years, COVID‐19 vaccination rollout was temporally associated with a 56% increase in HBsAg loss rates (peak 1.27 per 100 person‐years in 2022), followed by gradual waning. Negative control outcomes showed no similar pattern, supporting biological specificity. ABSTRACT Background and Aims Hepatitis
Jonggi Choi +6 more
wiley +1 more source
Identifying and Linking to Care and Treatment Persons With Hepatitis C Who Were Lost to Follow-Up, Georgia 2023-2024. [PDF]
Getia V +9 more
europepmc +1 more source
Prevalence of hepatitis c virus antibodies in hemodialysis patients
Gürsel ÖZGÜR +5 more
doaj
Functional study of two flexible regions of the hepatitis E virus ORF1 replicase. [PDF]
Mézière L +8 more
europepmc +1 more source
Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023). [PDF]
Berenguer J +43 more
europepmc +1 more source
Perspectives on Pertussis Prevention
Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley +1 more source
PREVALANCE OF HEPATITIS C VIRUS ANTIBODIES IN DIFFERENT GROUPS
Hüseyin TURGUT +5 more
doaj

